Column Capital Advisors, LLC Oncternal Therapeutics, Inc. Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
A detailed history of Column Capital Advisors, LLC transactions in Oncternal Therapeutics, Inc. stock. As of the latest transaction made, Column Capital Advisors, LLC holds 1,450 shares of ONCT stock, worth $2,218. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,450
Previous 1,450
-0.0%
Holding current value
$2,218
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ONCT
# of Institutions
3Shares Held
362KCall Options Held
0Put Options Held
0About Oncternal Therapeutics, Inc.
- Ticker ONCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,517,200
- Market Cap $84.9M
- Description
- Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...